Citations

Clear

1432 citation(s) found for "Uk, Nathan".

Faculty Opinions recommendation of Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.
Badley, Andrew D. , Cummins, Nathan W.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 2, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717980148.793473331 Get It

Use of individual feedback during human gross anatomy course for enhancing professional behaviors in doctor of physical therapy students
Youdas, James W., Hellyer, Nathan J. , Rindflesch, Aaron , Hollman, John H. , Krause, David A. , Hollman, John , Rindflesch, Aaron B

Mayo Clinic

Anatomical Sciences Education | March 18, 2013 | Volume: 6 | Issue: 5 | Pages: 324-331

10.1002/ase.1356 | PMID 23509010 Get It

Medical professionals and public consumers expect that new physical therapy graduates possess cognitive, technical, and behavioral skills required to provide safe and high‐quality care to patients. The purpose of this study was to determine if a repertoire of ten professional behaviors assessed at the beginning of doctorate of physical therapy education and before the first significant clinical internship could be enhanced in a semester course in gross human anatomy using individual formative feedback. During the human anatomy course, 28 first‐year physical therapy students completed six biweekly, anonymous self‐ and peer assessment surveys that targeted ten professional behaviors important to physical therapists. All professional behaviors were assessed using a five‐point Likert scale. Feedback reports occurred at week eight (mid‐semester) and week 16 (end‐of‐semester) and comprised the direct intervention components of this study. At the midpoint of the semester, professional behavior scores and narrative comments from weeks two, four, and six were compiled and shared with each student by one of three faculty members in a feedback session. Students then submitted biweekly self‐and peer professional behavior assessments (weeks 10, 12, and 14) for the remainder of the human anatomy course. Differences between preintervention and postintervention scores for each of the ten professional behaviors were compared using the Wilcoxon signed‐ranks test. Upon receiving mid‐semester individual feedback, students demonstrated significant improvement in each of the ten professional behaviors. Results from this study indicated a gross anatomy laboratory dissection experience during the first academic semester provided an effective opportunity for teaching and assessing professional behaviors of doctoral students in physical therapy. Anat Sci Educ 6: 324–331. © 2013 American Association of Anatomists.
Lung Cancer Screening Experience: A Retrospective Review of PET in 22 Non-Small Cell Lung Carcinomas Detected on Screening Chest CT in a High-Risk Population
Lindell, Rebecca M. , Hartman, Thomas E. , Swensen, Stephen J., Jett, James R., Midthun, David E. , Nathan, Mark A., Lowe, Val J.

Mayo Clinic

American Journal of Roentgenology | February 28, 2013 | Volume: 185 | Issue: 1 | Pages: 126-131

10.2214/ajr.185.1.01850126 | PMID 15972412 Get It

Time Interval Between Abnormalities Seen on CT and the Clinical Diagnosis of Pancreatic Cancer: Retrospective Review of CT Scans Obtained Before Diagnosis
Gangi, Sumana, Nathan, Mark A., Christensen, Jared A. , Harmsen, William S. , Crownhart, Brian S., Chari, Suresh T. , Fletcher, Joel G. , Chari, Suresh T

Mayo Clinic

American Journal of Roentgenology | February 28, 2013 | Volume: 182 | Issue: 4 | Pages: 897-903

10.2214/ajr.182.4.1820897 | PMID 15039161 Get It

Faculty Opinions recommendation of HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44.
Badley, Andrew D. , Cummins, Nathan W.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | February 8, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717964963.793470322 Get It

Risk Factors for Radiocontrast Nephropathy After Emergency Department Contrast‐enhanced Computerized Tomography
Traub, Stephen J., Kellum, John A. , Tang, Aimee, Cataldo, Lauren, Kancharla, Adarsh, Shapiro, Nathan I. , Kellum, John A

Mayo Clinic

Academic Emergency Medicine | January 14, 2013 | Volume: 20 | Issue: 1 | Pages: 40-45

10.1111/acem.12059 | PMID 23570477 Get It

AbstractObjectivesRadiocontrast nephropathy (RCN) is a known complication of procedures in which intravascular iodinated contrast material is used. The authors sought to determine the risk factors for RCN after emergency department (ED) contrast‐enhanced computerized tomography (CECT).MethodsThis was a retrospective case–control study of patients presenting to a tertiary care ED between January 1, 2004, and December 31, 2006. Inclusion criteria were CECT performed in the ED, serum creatinine measured prior to CECT, and serum creatinine measured 48 to 96 hours after CECT. Exclusion criterion was dialysis‐dependent renal failure prior to CECT. The outcome of RCN was defined as an absolute creatinine increase of greater than or equal to 0.5 mg/dL, or a 25% increase above baseline. The charts of all RCN patients and a random sample of non‐RCN patients were reviewed to document the presence or absence of potential risk factors. Univariate analysis was performed using chi‐square and multiple logistic regression applying a weighted technique to account for sampling of non‐RCN patients.ResultsAmong the 5,006 patients meeting inclusion criteria, 349 (7%) developed RCN. Multiple regression analysis demonstrated that serum creatinine > 2 mg/dL, liver disease, heart failure, hematocrit < 30%, hypertension, and diabetes were risk factors for RCN, whereas age > 75 years, vascular disease, and serum creatinine > 1.5 mg/dL were not. The area under the curve (AUC) for the model was 0.65. Although the risk of RCN increased with the number of risk factors present, we could not develop a model with sufficient diagnostic accuracy to guide clinical decision‐making.ConclusionsThe authors report risk factors for RCN in a large case–control study, but could not develop an accurate decision tool to identify patients at increased risk for RCN after ED CECT.
Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
Mertens, Joachim C. , Fingas, Christian D., Christensen, John D. , Smoot, Rory L. , Bronk, Steven F., Werneburg, Nathan W., Gustafson, Michael P. , Dietz, Allan B. , Roberts, Lewis R. , Sirica, Alphonse E. , Gores, Gregory J. , Roberts, Lewis R , Smoot, Rory L , Dietz, Allan B

Mayo Clinic

Cancer Research | December 5, 2012 | Volume: 73 | Issue: 2 | Pages: 897-907

10.1158/0008-5472.can-12-2130 | PMID 23221385 Get It

Abstract Cancer-associated fibroblasts (CAF) are abundant in the stroma of desmoplastic cancers where they promote tumor progression. CAFs are “activated” and as such may be uniquely susceptible to apoptosis. Using cholangiocarcinoma as a desmoplastic tumor model, we investigated the sensitivity of liver CAFs to the cytotoxic drug navitoclax, a BH3 mimetic. Navitoclax induced apoptosis in CAF and in myofibroblastic human hepatic stellate cells but lacked similar effects in quiescent fibroblasts or cholangiocarcinoma cells. Unlike cholangiocarcinoma cells, neither CAF nor quiescent fibroblasts expressed Mcl-1, a known resistance factor for navitoclax cytotoxicity. Explaining this paradox, we found that mitochondria isolated from CAFs or cells treated with navitoclax both released the apoptogenic factors Smac and cytochrome c, suggesting that they are primed for cell death. Such death priming in CAFs appeared to be due, in part, to upregulation of the proapoptotic protein Bax. Short hairpin RNA-mediated attenuation of Bax repressed navitoclax-mediated mitochondrial dysfunction, release of apoptogenic factors, and apoptotic cell death. In a syngeneic rat model of cholangiocarcinoma, navitoclax treatment triggered CAF apoptosis, diminishing expression of the desmoplastic extracellular matrix protein tenascin C, suppressing tumor outgrowth, and improving host survival. Together, our findings argue that navitoclax may be useful for destroying CAFs in the tumor microenvironment as a general strategy to attack solid tumors. Cancer Res; 73(2); 897–907. ©2012 AACR.
Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38
Escande, Carlos , Nin, Verónica , Price, Nathan L. , Capellini, Verena Kise , Gomes, Ana P., Barbosa, Maria Thereza , O’Neil, Luke, White, Thomas A. , Sinclair, David , Chini, Eduardo N. , Sinclair, David A

Mayo Clinic

Diabetes | November 20, 2012 | Volume: 62 | Issue: 4 | Pages: 1084-1093

10.2337/db12-1139 | PMID 23172919 Get It

Metabolic syndrome is a growing health problem worldwide. It is therefore imperative to develop new strategies to treat this pathology. In the past years, the manipulation of NAD+ metabolism has emerged as a plausible strategy to ameliorate metabolic syndrome. In particular, an increase in cellular NAD+ levels has beneficial effects, likely because of the activation of sirtuins. Previously, we reported that CD38 is the primary NAD+ase in mammals. Moreover, CD38 knockout mice have higher NAD+ levels and are protected against obesity and metabolic syndrome. Here, we show that CD38 regulates global protein acetylation through changes in NAD+ levels and sirtuin activity. In addition, we characterize two CD38 inhibitors: quercetin and apigenin. We show that pharmacological inhibition of CD38 results in higher intracellular NAD+ levels and that treatment of cell cultures with apigenin decreases global acetylation as well as the acetylation of p53 and RelA-p65. Finally, apigenin administration to obese mice increases NAD+ levels, decreases global protein acetylation, and improves several aspects of glucose and lipid homeostasis. Our results show that CD38 is a novel pharmacological target to treat metabolic diseases via NAD+-dependent pathways.
PATIENT SELF-ASSESSMENT FACTORS PREDICTIVE OF PERSISTENT DEPRESSIVE SYMPTOMS 6 MONTHS AFTER ENROLLMENT IN COLLABORATIVE CARE MANAGEMENT
Angstman, Kurt B. , Shippee, Nathan D. , MacLaughlin, Kathy L. , Rasmussen, Norman H., Wilkinson, John M. , Williams, Mark D. , Katzelnick, David J., Shippee, Nathan

Mayo Clinic

Depression and Anxiety | November 8, 2012 | Volume: 30 | Issue: 2 | Pages: 143-148

10.1002/da.22020 | PMID 23139162 Get It